Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.3285 EUR -3.38% Market Closed
Market Cap: 35.2m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Total Liabilities & Equity Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Total Liabilities & Equity
€15m
CAGR 3-Years
-39%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Total Liabilities & Equity
€466.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genfit SA
PAR:GNFT
Total Liabilities & Equity
€194.8m
CAGR 3-Years
13%
CAGR 5-Years
-10%
CAGR 10-Years
10%
Inventiva SA
PAR:IVA
Total Liabilities & Equity
€69.6m
CAGR 3-Years
-16%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Total Liabilities & Equity
€316.3m
CAGR 3-Years
21%
CAGR 5-Years
35%
CAGR 10-Years
22%
OSE Immunotherapeutics SA
PAR:OSE
Total Liabilities & Equity
€140.9m
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
N/A

See Also

What is Gensight Biologics SA's Total Liabilities & Equity?
Total Liabilities & Equity
15m EUR

Based on the financial report for Jun 30, 2024, Gensight Biologics SA's Total Liabilities & Equity amounts to 15m EUR.

What is Gensight Biologics SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-14%

Over the last year, the Total Liabilities & Equity growth was -10%. The average annual Total Liabilities & Equity growth rates for Gensight Biologics SA have been -39% over the past three years , -14% over the past five years .

Back to Top